6 August 2026

FDA Pharmaceuticals TGA

TGA reviews avacopan as new data submitted to FDA

9 July 2026

ANCA-associated vasculitis FDA Pharmaceuticals

Avacopan trial retracted as regulators diverge

2 April 2026

FDA Pharmaceuticals

FDA liver alert for avacopan

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

21 August 2025

FDA Fibromyalgia

FDA approves first new fibromyalgia therapy in 16 years

10 July 2025

FDA

FDA approves first treatment for life-threatening MAS in Still’s disease patients

1 May 2025

FDA gca2

Giant cell arteritis drug gets FDA and EMA nod

4 December 2024

FDA Pharmaceuticals

Hope for severe Sjögren’s disease

30 November 2023

FDA

CAR-T cell therapy under investigation by FDA

19 October 2023

Biosimilars FDA

Toci biosimilars approved overseas

9 March 2023

Biologics Corticosteroids FDA Polymyalgia Rheumatica

Finally, modern medicine for PMR

8 July 2021 SPONSORED

Biosimilars FDA Spondyloarthritis

How might subcutaneous infliximab impact the lives of your patients with RA?